AGP Executive Report
Last update: 10 hours agoCBD Delivery: Trait Biosciences says its CBD82S™ showed more than 100 times the skin permeation of conventional CBD in ex-vivo tests, plus improved intestinal transport; further research is needed to understand the results. Hemp Restrictions: Michigan industry advocates warn proposed federal THC limits could affect 80% to 95% of the CBD market, including full-spectrum oils and edibles. That’s their estimate, while state bills to ease growers’ costs remain stalled. Product Safety: A Colorado audit found major gaps in cannabis testing and oversight, with nearly 75% of marijuana processed for sale from 2023 to 2025 not tested for pesticides. Medical Access: Massachusetts lawmakers gave initial approval to a bill that could let veterans qualify for medical cannabis using VA documentation instead of a doctor’s recommendation.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.